Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Concord Drugs Limited has submitted a compliance certificate from its Registrar and Share Transfer Agent, Aarthi Consultants Private Limited, for the quarter ended 31st March 2026. The certificate confirms that the R&T Agent properly handled dematerialization requests received between 1st January 2026 and 31st March 2026. Specifically, the agent confirmed compliance with three key procedures: processing dematerialized securities that are listed on the stock exchange, mutilating and cancelling physical share certificates received from participants, and updating records to show the depository as the registered owner. This is a routine regulatory filing required under SEBI regulations.
This is a standard compliance filing with no direct impact on stock price or shareholder value. It simply confirms proper handling of dematerialization procedures during the quarter.